Peter Oblenis News Today

This Article profiles DistillerSRs global market growth and value from their AI evidence based literature research solution, used in the Pharma and Medical industry.

Ottawa, Canada September 28, 2022 --( PR.com )-- Building on its recent C$20 million growth financing, Evidence Partners® Inc., the market leader in AI-enabled literature review automation software and creator

Kanata-based software firm says demand for its software that helps streamline the medical research process has skyrocketed during the pandemic.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Kanata-based software firm says demand for its software that helps streamline the medical research process has skyrocketed during the pandemic.

/PRNewswire/ - Evidence Partners® Inc., the market leader in AI-enabled literature review automation software and creator of DistillerSR™, today announced that...

/PRNewswire/ - Evidence Partners® Inc., a market leader in AI-enabled literature review automation software and creator of DistillerSR™, today announced a...

By Dan Rubinstein When Peter O’Blenis was finishing his undergraduate Computer Science degree at Carleton University, he knew that he wanted to start a company someday. “It’s about building something from scratch,” he says, “and not having any limits — not having a ceiling over your head.” That entrepreneurial instinct led O’Blenis to launch a video game business within six months of graduating in 1993 and then, in 2001, to co-found a software firm called TrialStat. Evidence Par...

Article content What you need to know, at a glance Ontario is reporting 904 new laboratory-confirmed COVID-19 cases on the day lockdown restrictions lift in 27 public health regions, including Ottawa and the surrounding regions Prime Minister Justin Trudeau said Canada expects to receive its largest shipment of Pfizer-BioNTech vaccines to date this week, with another, larger shipment due next week Trudeau said he also spoke recently with executives from Moderna, and repeated his assurances that...